1st Quarter - Report

BGR GOVERNMENT AFFAIRS for NOVARTIS

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including supply chain, PBM policies, Inflation Reduction Act, cell, gene and radioligand therapies and/or issues impacting Novartis specifically

LobbyistCovered position, as disclosed
JOEL D. BAILEY COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA / Sr. LA Rep. Baron Hill
BRENT ALAN DEL MONTE Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee
DANIEL FARMER St. Asst Rep. Debbie Wasserman Schultz; Leg. Corr. Rep. Debbie Wasserman Schultz; Leg. Corr./Leg. Asst. Rep. Debbie Wasserman Schultz; Leg. Asst. Rep. Zack Space; Sr. Leg. Asst. Rep. Zack Space; Leg. Dir. Zack Space
REMY LEIGH BRIM MASON Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren
JOHN STONE Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee
ROBB WALTON Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Healthcare Aide Sen. Enzi

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.